信号转导及转录激活因子3信号传导与高免疫球蛋白E综合征 - Suppr

Suppr

超能文献

STAT3 signaling and the hyper-IgE syndrome.

作者信息

Levy David E, Loomis Cynthia A

出版信息

N Engl J Med. 2007 Oct 18;357(16):1655-8. doi: 10.1056/NEJMe078197. Epub 2007 Sep 19.

DOI:10.1056/NEJMe078197

PMID:17881746

Abstract

摘要

相似文献

STAT3 signaling and the hyper-IgE syndrome.

N Engl J Med. 2007 Oct 18;357(16):1655-8. doi: 10.1056/NEJMe078197. Epub 2007 Sep 19.

[STAT3 mutation identified in patients with Hyper-IgE syndrome].

Med Sci (Paris). 2008 Mar;24(3):242-3. doi: 10.1051/medsci/2008243242.

[Dominant negative STAT-3 mutations in hyper-IgE syndrome].

Ann Dermatol Venereol. 2008 May;135(5):432. doi: 10.1016/j.annder.2008.02.010. Epub 2008 Apr 10.

A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome.

J Allergy Clin Immunol. 2009 Apr;123(4):956-8. doi: 10.1016/j.jaci.2009.01.068.

Hyper IgE syndrome diagnosed in early infancy by gene analysis of STAT3 mutation.

Eur J Dermatol. 2011 Mar-Apr;21(2):254-5. doi: 10.1684/ejd.2010.1245.

STAT3 mutation in the original patient with Job's syndrome.

N Engl J Med. 2007 Oct 18;357(16):1667-8. doi: 10.1056/NEJMc076367.

A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.

Mol Immunol. 2010 Apr;47(7-8):1629-34. doi: 10.1016/j.molimm.2010.01.010. Epub 2010 Feb 9.

Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome.

Scand J Infect Dis. 2013 Mar;45(3):235-8. doi: 10.3109/00365548.2012.715750. Epub 2012 Sep 19.

Hyper-IgE syndrome.

Curr Opin Immunol. 2009 Oct;21(5):487-92. doi: 10.1016/j.coi.2009.07.013. Epub 2009 Aug 28.

Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES).

J Allergy Clin Immunol. 2012 Dec;130(6):1426-8. doi: 10.1016/j.jaci.2012.07.030. Epub 2012 Sep 13.

引用本文的文献

Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.

Cancers (Basel). 2024 Mar 31;16(7):1387. doi: 10.3390/cancers16071387.

Human-Fungal Pathogen Interactions from the Perspective of Immunoproteomics Analyses.

Int J Mol Sci. 2024 Mar 20;25(6):3531. doi: 10.3390/ijms25063531.

On Two Cases with Autosomal Dominant Hyper IgE Syndrome: Importance of Immunological Parameters for Clinical Course and Follow-Up.

Case Reports Immunol. 2020 Dec 2;2020:6694957. doi: 10.1155/2020/6694957. eCollection 2020.

Stat3 in osteocytes mediates osteogenic response to loading.

Bone Rep. 2019 Jul 29;11:100218. doi: 10.1016/j.bonr.2019.100218. eCollection 2019 Dec.

Design, synthesis and evaluation of ()-3-(7-(methyl(7-pyrrolo[2,3-]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor.

Medchemcomm. 2018 Jan 15;9(3):477-489. doi: 10.1039/c7md00568g. eCollection 2018 Mar 1.

Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):996-1001. doi: 10.1016/j.jaip.2017.06.041. Epub 2017 Sep 19.

Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.

J Clin Immunol. 2017 Oct;37(7):695-700. doi: 10.1007/s10875-017-0429-z. Epub 2017 Aug 13.

Hemoptysis in a Patient with Elevated Immunoglobulin E.

J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1054-1058. doi: 10.1016/j.jaip.2016.08.003. Epub 2016 Sep 29.

Signal transducer and activator of transcription 3 mutation with invasive eosinophilic disease.

Allergy Rhinol (Providence). 2012 Fall;3(2):e94-7. doi: 10.2500/ar.2012.3.0035. Epub 2012 Dec 13.

Leptin and mucosal immunity.

Mucosal Immunol. 2012 Sep;5(5):472-9. doi: 10.1038/mi.2012.40. Epub 2012 Jun 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

STAT3 signaling and the hyper-IgE syndrome.

N Engl J Med. 2007 Oct 18;357(16):1655-8. doi: 10.1056/NEJMe078197. Epub 2007 Sep 19.

[STAT3 mutation identified in patients with Hyper-IgE syndrome].

Med Sci (Paris). 2008 Mar;24(3):242-3. doi: 10.1051/medsci/2008243242.

[Dominant negative STAT-3 mutations in hyper-IgE syndrome].

Ann Dermatol Venereol. 2008 May;135(5):432. doi: 10.1016/j.annder.2008.02.010. Epub 2008 Apr 10.

A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome.

J Allergy Clin Immunol. 2009 Apr;123(4):956-8. doi: 10.1016/j.jaci.2009.01.068.

Hyper IgE syndrome diagnosed in early infancy by gene analysis of STAT3 mutation.

Eur J Dermatol. 2011 Mar-Apr;21(2):254-5. doi: 10.1684/ejd.2010.1245.

STAT3 mutation in the original patient with Job's syndrome.

N Engl J Med. 2007 Oct 18;357(16):1667-8. doi: 10.1056/NEJMc076367.

A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.

Mol Immunol. 2010 Apr;47(7-8):1629-34. doi: 10.1016/j.molimm.2010.01.010. Epub 2010 Feb 9.

Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome.

Scand J Infect Dis. 2013 Mar;45(3):235-8. doi: 10.3109/00365548.2012.715750. Epub 2012 Sep 19.

Hyper-IgE syndrome.

Curr Opin Immunol. 2009 Oct;21(5):487-92. doi: 10.1016/j.coi.2009.07.013. Epub 2009 Aug 28.

Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES).

J Allergy Clin Immunol. 2012 Dec;130(6):1426-8. doi: 10.1016/j.jaci.2012.07.030. Epub 2012 Sep 13.

引用本文的文献

Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.

Cancers (Basel). 2024 Mar 31;16(7):1387. doi: 10.3390/cancers16071387.

Human-Fungal Pathogen Interactions from the Perspective of Immunoproteomics Analyses.

Int J Mol Sci. 2024 Mar 20;25(6):3531. doi: 10.3390/ijms25063531.

On Two Cases with Autosomal Dominant Hyper IgE Syndrome: Importance of Immunological Parameters for Clinical Course and Follow-Up.

Case Reports Immunol. 2020 Dec 2;2020:6694957. doi: 10.1155/2020/6694957. eCollection 2020.

Stat3 in osteocytes mediates osteogenic response to loading.

Bone Rep. 2019 Jul 29;11:100218. doi: 10.1016/j.bonr.2019.100218. eCollection 2019 Dec.

Design, synthesis and evaluation of ()-3-(7-(methyl(7-pyrrolo[2,3-]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor.

Medchemcomm. 2018 Jan 15;9(3):477-489. doi: 10.1039/c7md00568g. eCollection 2018 Mar 1.

Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):996-1001. doi: 10.1016/j.jaip.2017.06.041. Epub 2017 Sep 19.

Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.

J Clin Immunol. 2017 Oct;37(7):695-700. doi: 10.1007/s10875-017-0429-z. Epub 2017 Aug 13.

Hemoptysis in a Patient with Elevated Immunoglobulin E.

J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1054-1058. doi: 10.1016/j.jaip.2016.08.003. Epub 2016 Sep 29.

Signal transducer and activator of transcription 3 mutation with invasive eosinophilic disease.

Allergy Rhinol (Providence). 2012 Fall;3(2):e94-7. doi: 10.2500/ar.2012.3.0035. Epub 2012 Dec 13.

Leptin and mucosal immunity.

Mucosal Immunol. 2012 Sep;5(5):472-9. doi: 10.1038/mi.2012.40. Epub 2012 Jun 13.